LIPOSOMAL BUPIVACAINE
Clinical trials for LIPOSOMAL BUPIVACAINE explained in plain language.
Never miss a new study
Get alerted when new LIPOSOMAL BUPIVACAINE trials appear
Sign up with your email to follow new studies for LIPOSOMAL BUPIVACAINE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New painkiller may reduce need for opioids after wisdom tooth surgery
Symptom relief CompletedThis study tested whether a long-lasting painkiller (Exparel) works better than a standard one (bupivacaine) for pain after removing all four wisdom teeth. 82 adults took part, and they reported their pain and any side effects for four days after surgery. The goal was to see if E…
Matched conditions: LIPOSOMAL BUPIVACAINE
Phase: PHASE4 • Sponsor: Case Western Reserve University • Aim: Symptom relief
Last updated May 26, 2026 08:29 UTC
-
New painkiller may stop the 'Rebound' pain after shoulder surgery
Symptom relief CompletedThis study tested whether a long-acting painkiller (liposomal bupivacaine) could prevent the sudden severe pain that often occurs when a nerve block wears off after shoulder surgery. 100 adults having shoulder arthroscopy received either the new painkiller or a standard one (ropi…
Matched conditions: LIPOSOMAL BUPIVACAINE
Phase: PHASE4 • Sponsor: Liu Jiuhong • Aim: Symptom relief
Last updated May 26, 2026 08:28 UTC